Home » News » AIM News » Allergy Therapeutics Plc Presentation at Jefferies Healthcare Conference
Allergy Therapeutics plc

Allergy Therapeutics Plc Presentation at Jefferies Healthcare Conference

Allergy Therapeutics Plc (LON:AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announced that Manuel Llobet, CEO, and Nick Wykeman, CFO, will attend the Jefferies Healthcare Conference in London on Wednesday 14 November 2018.

Nick Wykeman, CFO of Allergy Therapeutics, will lead an investor presentation at 15.20 GMT on Wednesday 14 November.